Kinetics and mechanism of the reaction of aminoguanidine with the α-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions
- 1 July 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (1), 55-65
- https://doi.org/10.1016/s0006-2952(00)00287-2
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injuryDiabetologia, 1997
- The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteinsBiochemical Pharmacology, 1994
- Advanced glycation end products contribute to amyloidosis in Alzheimer disease.Proceedings of the National Academy of Sciences, 1994
- Mechanism of Inhibition of Advanced Glycosylation by Aminoguanidine in VitroJournal of Carbohydrate Chemistry, 1993
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.JCI Insight, 1993
- Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.JCI Insight, 1993
- Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.Proceedings of the National Academy of Sciences, 1992
- The reaction of some dicarbonyl sugars with aminoguanidineCarbohydrate Research, 1992
- Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.Proceedings of the National Academy of Sciences, 1991
- Role of Glycation in Modification of Lens Crystallins in Diabetic and Nondiabetic Senile CataractsDiabetes, 1991